Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated muc1 glycopeptides and the toll-like receptor 2 agonist pam3CysSer
- Brendan L. Wilkinson
- , Stephanie Day
- , Lara R. Malins
- , Vasso Apostolopoulos
- , Richard J. Payne
Research output: Contribution to journal › Article › peer-review
146
Citations
(Scopus)